Nikkei Business
Complete projections 2021
Have we reached bottom, or is the worst yet to come?
U.S. Pfizer applies for authorization for use in Japan
Barriers of clinical trials for a Japan-produced vaccine
Artisans and AI: a threat, a replacement, or something else to each other?
Friendly rivalry engenders a virtuous circle
10 years from the Arab spring
The Middle East today